Cooperation on the Development of a Malaria Vaccine(12/23/2005) The malaria vaccine GMZ2 to be tested in a Phase I clinical trial in Tübingen Vakzine Projekt Management GmbH (VPM) and the European Malaria Vaccine Initiative (EMVI) are cooperating in compiling and submitting the Phase I clinical trial application of malaria vaccine GMZ2 to the Paul-Ehrlich-Institute and to the Ethics ...
SEQUENOM Announces Gene Expression Agreement With the University of Tuebingen(08/18/2004) MassARRAY(TM) Compact System Reference Site Established SEQUENOM, Inc. announced an agreement with the Institute of Medical Genetics and the Microarray Facility at the University of Tuebingen in Germany for SEQUENOM's MassARRAY Quantitative Gene Expression (QGE) application. The Institute is one of the ...
Top